Ongoing IO Clinical Trials, Scientific Breakthroughs, and Future Opportunities: An Update

Wednesday, March 8, 2023

3:00 PM – 4:30 PM

Location:Phoenix Convention Center, 228AB

CE: 1.5 Credits

Coordinator(s)

RA

Rony Avritscher, MD

Professor of Radiology
MD Anderson Cancer Center

Disclosure(s): No relevant disclosure to display
TG

Terence Gade, MD PhD

Assistant Professor of Radiology
Penn Image-Guided Interventions (PIGI) Lab, Hospital of the University of Pennsylvania

Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Instylla, Inc.: Research Grant Recipient (Ongoing); Trisalus Life Sciences: Advisory Committee or Review Panel Member (Ongoing)

Disclosure(s):

Rony Avritscher, MD: No relevant disclosure to display

Terence P. Gade, MD PhD: Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Instylla, Inc.: Research Grant Recipient (Ongoing); Trisalus Life Sciences: Advisory Committee or Review Panel Member (Ongoing)

The session will focus on the latest developments in the field of interventional oncology. Speakers will be providing updates on scientific breakthroughs in preclinical and clinical research, such as advances in immunotherapy and combination approaches, as well as updates on ongoing clinical trials.

Learning Objectives:

To describe the latest updates in the ongoing clinical trials in interventional oncology
To define the impact of locoregional therapies in tumor immunity
To describe the current combination therapy strategies in interventional oncology

Presentations:

3:00 PM – 3:14 PM

New and evolving clinical trials: embolotherapy
Speaker: Michael C. Soulen, MD – Abramson cancer Center, University of Pennsylvania
3:14 PM – 3:28 PM

New and evolving clinical trials: Ablation
Speaker: Constantinos T. Sofocleous, MD PhD – Weill Cornell Medical College Memorial Sloan-Kettering Cancer Center
3:28 PM – 3:41 PM

Immunological effects of locoregional therapies
Speaker: Lynn J. Savic, MD, PhD (she/her/hers) – University Hospital Charité Berlin
3:41 PM – 3:54 PM

Immunometabolism in liver cancer: a new concept for interventional oncologists
Speaker: Jessica G. Santana, M.S. – Yale Department of Engineering and Applied Science
3:54 PM – 4:07 PM

Molecular Subtyping to Inform Treatment Selection for Hepatocellular Carcinoma
Speaker: Kelley Weinfurtner, MD (she/her/hers) – University of Pennsylvania
4:07 PM – 4:20 PM

Combination therapies in Interventional Oncology
Speaker: Sarah B. White, MD, MS, FSIR – Medical College of Wisconsin
4:20 PM – 4:30 PM

Q & A